These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 21355080)
1. Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma. Opel D; Naumann I; Schneider M; Bertele D; Debatin KM; Fulda S Clin Cancer Res; 2011 May; 17(10):3233-47. PubMed ID: 21355080 [TBL] [Abstract][Full Text] [Related]
2. PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis. Bender A; Opel D; Naumann I; Kappler R; Friedman L; von Schweinitz D; Debatin KM; Fulda S Oncogene; 2011 Jan; 30(4):494-503. PubMed ID: 20856197 [TBL] [Abstract][Full Text] [Related]
3. Bortezomib primes neuroblastoma cells for TRAIL-induced apoptosis by linking the death receptor to the mitochondrial pathway. Naumann I; Kappler R; von Schweinitz D; Debatin KM; Fulda S Clin Cancer Res; 2011 May; 17(10):3204-18. PubMed ID: 21459798 [TBL] [Abstract][Full Text] [Related]
4. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo. Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553 [TBL] [Abstract][Full Text] [Related]
5. Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma. Graab U; Hahn H; Fulda S Oncotarget; 2015 Apr; 6(11):8722-35. PubMed ID: 25749378 [TBL] [Abstract][Full Text] [Related]
6. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma. Guenther MK; Graab U; Fulda S Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925 [TBL] [Abstract][Full Text] [Related]
7. PI3K Inhibitor Combined With Chemotherapy Can Enhance the Apoptosis of Neuroblastoma Cells In Vitro and In Vivo. Geng X; Xie L; Xing H Technol Cancer Res Treat; 2016 Oct; 15(5):716-22. PubMed ID: 26224681 [TBL] [Abstract][Full Text] [Related]
8. Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis. Unterkircher T; Cristofanon S; Vellanki SH; Nonnenmacher L; Karpel-Massler G; Wirtz CR; Debatin KM; Fulda S Clin Cancer Res; 2011 Jun; 17(12):4019-30. PubMed ID: 21525171 [TBL] [Abstract][Full Text] [Related]
9. Chloroquine overcomes resistance of lung carcinoma cells to the dual PI3K/mTOR inhibitor PI103 by lysosome-mediated apoptosis. Enzenmüller S; Gonzalez P; Debatin KM; Fulda S Anticancer Drugs; 2013 Jan; 24(1):14-9. PubMed ID: 23111416 [TBL] [Abstract][Full Text] [Related]
10. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347 [TBL] [Abstract][Full Text] [Related]
11. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma. Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Bhanot U; Hasel C; Möller P; Gschwend JE; Simmet T; Debatin KM; Fulda S Cancer Res; 2009 Mar; 69(6):2425-34. PubMed ID: 19258513 [TBL] [Abstract][Full Text] [Related]
12. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Ravi R; Bedi A Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014 [TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Opel D; Westhoff MA; Bender A; Braun V; Debatin KM; Fulda S Cancer Res; 2008 Aug; 68(15):6271-80. PubMed ID: 18676851 [TBL] [Abstract][Full Text] [Related]
15. Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3. Choi WY; Jin CY; Han MH; Kim GY; Kim ND; Lee WH; Kim SK; Choi YH Anticancer Res; 2009 Nov; 29(11):4457-65. PubMed ID: 20032392 [TBL] [Abstract][Full Text] [Related]
16. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways. Thanaketpaisarn O; Waiwut P; Sakurai H; Saiki I Int J Oncol; 2011 Jul; 39(1):279-85. PubMed ID: 21537836 [TBL] [Abstract][Full Text] [Related]